CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-10-27 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −5,038 | $41.80 | $211K | 70,737 |
| 2015-10-27 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,298 | 0 | ||
| 2015-10-27 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −5,038 | 50,962 | ||
| 2015-10-26 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +11,491 | $16.53 | $190K | 82,228 |
| 2015-10-26 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −11,491 | $41.80 | $480K | 70,737 |
| 2015-10-26 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −11,491 | 7,298 | ||
| 2015-10-23 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +940 | $16.53 | $16K | 71,677 |
| 2015-10-23 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −940 | $41.80 | $39K | 70,737 |
| 2015-10-23 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −940 | 18,789 | ||
| 2015-10-21 | MARSH RICHARD M E.V.P., General Counsel | Gift | −2,628 | 70,123 | ||
| 2015-10-17 | Riggsbee Richard Bryan Chief Financial Officer | Shares withheld for taxes | −2,427 | $39.31 | $95K | 27,573 |
| 2015-10-06 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion | +1 | $16.53 | $17 | 66,544 |
| 2015-10-06 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion | +2,346 | $30.12 | $71K | 68,890 |
| 2015-10-06 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion | +3,861 | $30.34 | $117K | 72,751 |
| 2015-10-06 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion · Incentive Stock Option (right to buy) | −1 | 0 | ||
| 2015-10-06 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion · Incentive Stock Option (right to buy) | −2,346 | 0 | ||
| 2015-10-06 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion · Incentive Stock Option (right to buy) | −3,861 | 0 | ||
| 2015-09-17 | McDade Ralph L President Myriad RBM, Inc. | Shares withheld for taxes | −2,188 | $41.39 | $91K | 55,157 |
| 2015-09-17 | Wenstrup Richard Chief Medical Officer | Shares withheld for taxes | −931 | $41.39 | $39K | 22,069 |
| 2015-09-17 | Ford Alexander President, MGL | Shares withheld for taxes | −1,937 | $41.39 | $80K | 34,094 |
Page 52 of 60 · 1,194 trades